Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 879,509 | 358,409 | 210,071 | 273,753 | 135,246 |
| Cost of Goods | 340,246 | 170,313 | 91,969 | 107,656 | 72,248 |
| Gross Profit | 539,263 | 188,096 | 118,102 | 166,097 | 62,998 |
| Operating Expenses | 146,185 | 117,996 | 115,148 | 90,246 | 74,493 |
| Operating Income | 393,324 | 70,413 | 3,923 | 76,507 | -11,247 |
| Interest Expense | 167 | 246 | 4,782 | 7,162 | 3,796 |
| Other Income | 782 | 810 | 26,868 | 4,652 | 3,139 |
| Pre-tax Income | 393,939 | 70,977 | 26,009 | 73,997 | -11,904 |
| Income Tax | 143,521 | 21,006 | 10,069 | -51,351 | 140 |
| Net Income Continuous | 250,418 | 49,971 | 15,940 | 125,348 | -12,044 |
| Minority Interests | N/A | -90 | -47 | -62 | N/A |
| Net Income | $250,418 | $50,061 | $15,987 | $125,410 | $-12,044 |
| EPS Basic Total Ops | 4.04 | 0.83 | 0.27 | 2.13 | -0.20 |
| EPS Basic Continuous Ops | 4.04 | 0.83 | 0.27 | 2.13 | -0.20 |
| EPS Diluted Total Ops | 3.82 | 0.82 | 0.26 | 2.05 | -0.20 |
| EPS Diluted Continuous Ops | 3.82 | 0.82 | 0.26 | 2.05 | -0.20 |
| EBITDA(a) | $514,646 | $106,558 | $53,691 | $144,430 | $22,487 |